» Articles » PMID: 26827874

Mobilization of Hematopoietic Stem Cells with Highest Self-renewal by G-CSF Precedes Clonogenic Cell Mobilization Peak

Overview
Journal Exp Hematol
Specialty Hematology
Date 2016 Feb 2
PMID 26827874
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Harvest of granulocyte colony-stimulating factor (G-CSF)-mobilized hematopoietic stem cells (HSCs) begins at day 5 of G-CSF administration, when most donors have achieved maximal mobilization. This is based on surrogate markers for HSC mobilization, such as CD34(+) cells and colony-forming activity in blood. However, CD34(+) cells or colony-forming units in culture (CFU-C) are heterogeneous cell populations with hugely divergent long-term repopulation potential on transplantation. HSC behavior is influenced by the vascular bed in the vicinity of which they reside. We hypothesized that G-CSF may mobilize sequentially cells proximal and more distal to bone marrow venous sinuses where HSCs enter the blood. We addressed this question with functional serial transplantation assays using blood and bone marrow after specific time points of G-CSF treatment in mice. We found that in mice, blood collected after only 48 hours of G-CSF administration was as enriched in serially reconstituting HSCs as blood collected at 5 days of G-CSF treatment. Similarly, mobilized Lin(-)CD34(+) cells were relatively enriched in more primitive Lin(-)CD34(+)CD38(-) cells at day 2 of G-CSF treatment compared with later points in half of human donors tested (n = 6). This suggests that in both humans and mice, hematopoietic progenitor and stem cells do not mobilize uniformly according to their maturation stage, with most potent HSCs mobilizing as early as day 2 of G-CSF.

Citing Articles

Effect of bone marrow niche on hematopoietic stem cells.

Niazi V, Ghafouri-Fard S Histochem Cell Biol. 2024; 163(1):19.

PMID: 39714560 DOI: 10.1007/s00418-024-02348-z.


Assessment of non-myelotoxic agents as a preparatory regimen for hematopoietic stem cell gene therapy.

Seker M, Erol O, Pervin B, Wagemaker G, van Til N, Aerts-Kaya F Hum Cell. 2024; 38(1):9.

PMID: 39460845 DOI: 10.1007/s13577-024-01130-6.


Stem Cells Collection and Mobilization in Adult Autologous/Allogeneic Transplantation: Critical Points and Future Challenges.

Prisciandaro M, Santinelli E, Tomarchio V, Tafuri M, Bonchi C, Palazzo G Cells. 2024; 13(7.

PMID: 38607025 PMC: 11011310. DOI: 10.3390/cells13070586.


Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency.

Soukup A, Bresnick E Blood Adv. 2023; 7(24):7564-7575.

PMID: 37871305 PMC: 10761364. DOI: 10.1182/bloodadvances.2023011003.


Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis.

Romano L, Seu K, Papoin J, Muench D, Konstantinidis D, Olsson A Blood. 2022; 140(14):1621-1634.

PMID: 35862735 PMC: 9707396. DOI: 10.1182/blood.2022015724.